Table 1

Baseline characteristics of study cohorts and number of deaths from CVD, non-CVD, and all causes in individuals with FPG <6.1 mmol/l and 2-h plasma glucose <7.8 mmol/l

Countries and studiesn (men/women)Age (years)FPG (mmol/l)*2-h PG (mmol/l)*No. of deaths (men/women)Follow-up years
CVDNon-CVDAll cause
Demark
    Glostrup461/54454 (39–70)5.4 (5.4–5.5)5.9 (5.8–5.9)98/6168/47166/10817.1 (15.6, 19.1)
Finland
    East-West187/—76 (70–90)5.2 (5.1–5.3)5.6 (5.5–5.8)69/—34/—103/—8.8 (4.6, 14.8)
    FINRISK 1987985/1,10053 (44–64)5.1 (5.1–5.1)5.6 (5.5–5.6)125/5884/60209/11819.8 (19.8, 19.9)
    FINRISK 1992566/81454 (44–64)5.3 (5.2–5.3)5.5 (5.4–5.5)28/1116/3644/4714.9 (14.8, 14.9)
    FINRISK 2002842/1,32357 (45–74)5.5 (5.5–5.5)5.5 (5.5–5.6)5/39/714/104.8 (4.8, 4.9)
    Helsinki policemen687/—45 (31–69)5.6 (5.5–5.6)5.4 (5.3–5.5)199/—108/—307/—32.9 (21.8, 36.2)
    Oulu93/17255 (55–55)5.4 (5.4–5.5)6.1 (5.9–6.2)1/29/610/810.0 (10.0, 10.1)
    Vantaa147/18865 (64–66)5.3 (5.2–5.3)6.2 (6.1–6.3)16/63/319/913.3 (13.1, 13.6)
Italy
    Cremona Study618/79457 (40–88)5.0 (5.0–5.0)4.9 (4.9–5.0)54/4766/42120/8915.1 (14.6, 15.6)
Poland
    MONICA98/11657 (44–73)5.3 (5.2–5.3)5.7 (5.5–5.8)9/13/212/36.5 (6.4, 6.5)
Sweden
    Malmö—/83454 (48–57)5.6 (5.6–5.7)6.6 (6.5–6.7)—/11—/31—/4214.6 (13.7, 17.8)
    MONICA1,315/1,36546 (25–74)5.1 (5.1–5.1)5.2 (5.2–5.3)31/1122/2153/3212.6 (2.6, 16.6)
    ULSAM651/—71 (70–74)5.1 (5.1–5.1)5.8 (5.7–5.9)62/—65/—127/—10.2 (9.1, 11.1)
The Netherlands
    Hoorn Study798/97561 (49–77)5.3 (5.2–5.3)5.0 (4.9–5.0)41/1941/3182/508.9 (8.3, 9.3)
    Zutphen Study289/—76 (70–90)5.3 (5.2–5.3)5.1 (5.0–5.7)29/—13/—42/—4.7 (4.6, 4.8)
U.K.
    ELY262/41153 (40–67)5.5 (5.5–5.5)5.6 (5.5–5.7)11/313/1724/2014.6 (13.9, 15.4)
    Goodinge Study214/34652 (39–76)5.7 (5.6–5.7)5.5 (5.4–5.6)10/77/1417/218.7 (8.4, 9.0)
    Newcastle Heart Project224/25453 (30–76)5.5 (5.5–5.5)5.5 (5.4–5.6)13/211/1224/148.9 (8.5, 9.3)
    Whitehall II study4,129/1,63849 (39–62)5.1 (5.1–5.2)5.2 (5.2–5.3)26/439/2265/265.9 (5.6, 6.1)
Total12,566/10,87454 (25–90)5.3 (5.2–5.3)5.4 (5.4–5.4)827/246611/3511,438/5979.0 (5.8, 14.9)
  • Data are n, mean (range), or median (25th, 75th percentiles) unless otherwise indicated.

  • *Age-adjusted means (95% CIs). MONICA, Monitoring of Trends and Determinants in Cardiovascular Disease; PG, plasma glucose; ULSAM, Uppsala Longitudinal Study of Adult Men.